Related Experiment Video
Updated: Sep 9, 2025

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
Published on: June 10, 2022
Effects of Nucleoside Modifications on mRNA Translation: Choosing the Right Modifications
1Division of Cancer Medicine, Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. mosioud@medisin.uio.no.
Abstract:
The success of messenger RNA (mRNA)-based vaccines against SARS-CoV-2 during the COVID-19 pandemic has driven significant advancements in mRNA-based therapeutics. Key innovations include the use of modified nucleosides and ionizable lipid nanoparticles. Modified mRNA is produced through in vitro transcription, typically employing phage T7 RNA polymerase along with a DNA template and ribonucleoside triphosphates. Chemical modifications at the 5-position of pyrimidines, (cytosine and uridine) are generally well tolerated by T7 RNA polymerase and can reduce innate immune activation, though their effects on translation vary considerably. Therefore, the nature and codon-positions of these modifications, as well as the mRNA sequence, should be considered when designing mRNA therapeutics. This chapter details the production, purification, and evaluation of translation in human cells for modified mRNA containing 5-methyluridine, 5-methoxyuridine, 5-hydroxymethyluridine, pseudouridine, N1-methylpseudouridine, or N1-ethylpseudouridine.
Related Concept Videos
Nuclear Export of mRNA
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
RNA Stability
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Types of RNA
RNA Performs Diverse...

